Advertisement

Index by author

October 01, 2000; Volume 58,Issue 4

A

  1. Abumiya, Takeo

    1. 15-Deoxy-Δ12,14-prostaglandin J2Induces G1 Arrest and Differentiation Marker Expression in Vascular Smooth Muscle Cells
      Yoshikazu Miwa, Toshiyuki Sasaguri, Hiroyasu Inoue, Yoji Taba, Akio Ishida and Takeo Abumiya
      Molecular Pharmacology October 2000, 58 (4) 837-844; DOI: https://doi.org/10.1124/mol.58.4.837

  2. Arai, Amy C.

    1. Effects of the Potent Ampakine CX614 on Hippocampal and Recombinant AMPA Receptors: Interactions with Cyclothiazide and GYKI 52466
      Amy C. Arai, Markus Kessler, Gary Rogers and Gary Lynch
      Molecular Pharmacology October 2000, 58 (4) 802-813; DOI: https://doi.org/10.1124/mol.58.4.802

  3. Auzou, Gilles

    1. A Single Amino Acid Mutation of Ala-773 in the Mineralocorticoid Receptor Confers Agonist Properties to 11β-Substituted Spirolactones
      Gilles Auzou, Jérôme Fagart, Anny Souque, Chantal Hellal-Lévy, Jean-Marie Wurtz, Dino Moras and Marie-Edith Rafestin-Oblin
      Molecular Pharmacology October 2000, 58 (4) 684-691; DOI: https://doi.org/10.1124/mol.58.4.684

B

  1. Bayne, Marvin

    1. Identification of a Human Gastrointestinal Tract and Immune System Receptor for the Peptide Neuromedin U
      Joseph A. Hedrick, Kelley Morse, LiXin Shan, Xudong Qiao, Ling Pang, Suke Wang, Thomas Laz, Eric L. Gustafson, Marvin Bayne and Frederick J. Monsma
      Molecular Pharmacology October 2000, 58 (4) 870-875; DOI: https://doi.org/10.1124/mol.58.4.870

  2. Benovic, Jeffrey L.

    1. Mechanisms of Agonist-Induced Down-Regulation of the Human κ-Opioid Receptor: Internalization Is Required for Down-Regulation
      Jian-Guo Li, Jeffrey L. Benovic and Lee-Yuan Liu-Chen
      Molecular Pharmacology October 2000, 58 (4) 795-801; DOI: https://doi.org/10.1124/mol.58.4.795

  3. Bodin, Laurent

    1. Duplications and Defects in the CYP2A6 Gene: Identification, Genotyping, and In Vivo Effects on Smoking
      Yushu Rao, Ewa Hoffmann, Mohammad Zia, Laurent Bodin, Marilyn Zeman, Edward M. Sellers and Rachel F. Tyndale
      Molecular Pharmacology October 2000, 58 (4) 747-755; DOI: https://doi.org/10.1124/mol.58.4.747

C

  1. Cayla, Cécile

    1. Transcriptional Down-Regulation of the Human α2C-Adrenergic Receptor by cAMP
      Stéphane Schaak, Cécile Cayla, Anastasios Lymperopoulos, Christodoulos Flordellis, Daniel Cussac, Colette Denis and Hervé Paris
      Molecular Pharmacology October 2000, 58 (4) 821-827; DOI: https://doi.org/10.1124/mol.58.4.821

  2. Chaminade, Françoise

    1. Cellular Resistance to the Antitumor DNA Topoisomerase II Inhibitor S16020-2: Importance of the N-[2(Dimethylamino)ethyl]carbamoyl Side Chain
      Sandrine Le Mée, Françoise Chaminade, Charlotte Delaporte, Judith Markovits, Jean-Marie Saucier and Alain Jacquemin-Sablon
      Molecular Pharmacology October 2000, 58 (4) 709-718; DOI: https://doi.org/10.1124/mol.58.4.709

  3. Chesnoy-Marchais, Dominique

    1. Glycine Receptor β Subunits Play a Critical Role in Potentiation of Glycine Responses by ICS-205,930
      Stephane Supplisson and Dominique Chesnoy-Marchais
      Molecular Pharmacology October 2000, 58 (4) 763-770; DOI: https://doi.org/10.1124/mol.58.4.763

  4. Chidiac, Peter

    1. RGS3 Is a GTPase-Activating Protein for Giα and Gqα and a Potent Inhibitor of Signaling by GTPase-Deficient Forms of Gqα and G11α
      Astrid Scheschonka, Carmen W. Dessauer, Srikumar Sinnarajah, Peter Chidiac, Chong-Shan Shi and John H. Kehrl
      Molecular Pharmacology October 2000, 58 (4) 719-728; DOI: https://doi.org/10.1124/mol.58.4.719

  5. Cussac, Daniel

    1. Transcriptional Down-Regulation of the Human α2C-Adrenergic Receptor by cAMP
      Stéphane Schaak, Cécile Cayla, Anastasios Lymperopoulos, Christodoulos Flordellis, Daniel Cussac, Colette Denis and Hervé Paris
      Molecular Pharmacology October 2000, 58 (4) 821-827; DOI: https://doi.org/10.1124/mol.58.4.821

D

  1. Dalton, James T.

    1. Mdr1 Limits CYP3A Metabolism in Vivo
      Lu-Bin Lan, James T. Dalton and Erin G. Schuetz
      Molecular Pharmacology October 2000, 58 (4) 863-869; DOI: https://doi.org/10.1124/mol.58.4.863

  2. Davies, Martin

    1. Characterization of the Interaction of Zopiclone with γ-Aminobutyric Acid Type A Receptors
      Martin Davies, J. Glen Newell, Jason M. C. Derry, Ian L. Martin and Susan M. J. Dunn
      Molecular Pharmacology October 2000, 58 (4) 756-762; DOI: https://doi.org/10.1124/mol.58.4.756

  3. Dehal, Shangara S.

    1. Interaction of Methoxychlor and Related Compounds with Estrogen Receptor α and β, and Androgen Receptor: Structure-Activity Studies
      Kevin W. Gaido, Susan C. Maness, Donald P. McDonnell, Shangara S. Dehal, David Kupfer and Stephen Safe
      Molecular Pharmacology October 2000, 58 (4) 852-858; DOI: https://doi.org/10.1124/mol.58.4.852

  4. Delaporte, Charlotte

    1. Cellular Resistance to the Antitumor DNA Topoisomerase II Inhibitor S16020-2: Importance of the N-[2(Dimethylamino)ethyl]carbamoyl Side Chain
      Sandrine Le Mée, Françoise Chaminade, Charlotte Delaporte, Judith Markovits, Jean-Marie Saucier and Alain Jacquemin-Sablon
      Molecular Pharmacology October 2000, 58 (4) 709-718; DOI: https://doi.org/10.1124/mol.58.4.709

  5. Denis, Colette

    1. Transcriptional Down-Regulation of the Human α2C-Adrenergic Receptor by cAMP
      Stéphane Schaak, Cécile Cayla, Anastasios Lymperopoulos, Christodoulos Flordellis, Daniel Cussac, Colette Denis and Hervé Paris
      Molecular Pharmacology October 2000, 58 (4) 821-827; DOI: https://doi.org/10.1124/mol.58.4.821

  6. Derry, Jason M. C.

    1. Characterization of the Interaction of Zopiclone with γ-Aminobutyric Acid Type A Receptors
      Martin Davies, J. Glen Newell, Jason M. C. Derry, Ian L. Martin and Susan M. J. Dunn
      Molecular Pharmacology October 2000, 58 (4) 756-762; DOI: https://doi.org/10.1124/mol.58.4.756

  7. Dessauer, Carmen W.

    1. RGS3 Is a GTPase-Activating Protein for Giα and Gqα and a Potent Inhibitor of Signaling by GTPase-Deficient Forms of Gqα and G11α
      Astrid Scheschonka, Carmen W. Dessauer, Srikumar Sinnarajah, Peter Chidiac, Chong-Shan Shi and John H. Kehrl
      Molecular Pharmacology October 2000, 58 (4) 719-728; DOI: https://doi.org/10.1124/mol.58.4.719

  8. Di Angelantonio, Silvia

    1. Rapid Relief of Block by Mecamylamine of Neuronal Nicotinic Acetylcholine Receptors of Rat Chromaffin Cells In Vitro: An Electrophysiological and Modeling Study
      Rashid A. Giniatullin, Elena M. Sokolova, Silvia Di Angelantonio, Andrei Skorinkin, Maria V. Talantova and Andrea Nistri
      Molecular Pharmacology October 2000, 58 (4) 778-787; DOI: https://doi.org/10.1124/mol.58.4.778

  9. Dunn, Susan M. J.

    1. Characterization of the Interaction of Zopiclone with γ-Aminobutyric Acid Type A Receptors
      Martin Davies, J. Glen Newell, Jason M. C. Derry, Ian L. Martin and Susan M. J. Dunn
      Molecular Pharmacology October 2000, 58 (4) 756-762; DOI: https://doi.org/10.1124/mol.58.4.756

E

  1. Elizondo, Guillermo

    1. Aryl Hydrocarbon Receptor Is Required for p300-Mediated Induction of DNA Synthesis by Adenovirus E1A
      Masahiro Tohkin, Morio Fukuhara, Guillermo Elizondo, Shuhei Tomita and Frank J. Gonzalez
      Molecular Pharmacology October 2000, 58 (4) 845-851; DOI: https://doi.org/10.1124/mol.58.4.845

  2. Ellington, Michelle L.

    1. Cyclosporin A Selectively Inhibits Mitogen-Induced Cyclooxygenase-2 Gene Transcription in Vascular Smooth Muscle Cells
      Aaron M. Robida, Kaiming Xu, Michelle L. Ellington and T. J. Murphy
      Molecular Pharmacology October 2000, 58 (4) 701-708; DOI: https://doi.org/10.1124/mol.58.4.701

  3. Erdös, Ervin G.

    1. Human Bradykinin B2 Receptor Is Activated by Kallikrein and Other Serine Proteases
      Claudie Hecquet, Fulong Tan, Branislav M. Marcic and Ervin G. Erdös
      Molecular Pharmacology October 2000, 58 (4) 828-836; DOI: https://doi.org/10.1124/mol.58.4.828

F

  1. Fagart, Jérôme

    1. A Single Amino Acid Mutation of Ala-773 in the Mineralocorticoid Receptor Confers Agonist Properties to 11β-Substituted Spirolactones
      Gilles Auzou, Jérôme Fagart, Anny Souque, Chantal Hellal-Lévy, Jean-Marie Wurtz, Dino Moras and Marie-Edith Rafestin-Oblin
      Molecular Pharmacology October 2000, 58 (4) 684-691; DOI: https://doi.org/10.1124/mol.58.4.684

  2. Flordellis, Christodoulos

    1. Transcriptional Down-Regulation of the Human α2C-Adrenergic Receptor by cAMP
      Stéphane Schaak, Cécile Cayla, Anastasios Lymperopoulos, Christodoulos Flordellis, Daniel Cussac, Colette Denis and Hervé Paris
      Molecular Pharmacology October 2000, 58 (4) 821-827; DOI: https://doi.org/10.1124/mol.58.4.821

  3. Fredholm, Bertil B.

    1. Adenosine A2A Receptors are Colocalized with and Activate Golf in Rat Striatum
      Björn Kull, Per Svenningsson and Bertil B. Fredholm
      Molecular Pharmacology October 2000, 58 (4) 771-777; DOI: https://doi.org/10.1124/mol.58.4.771

  4. Fridkin, Mati

    1. Organic Vanadium Chelators Potentiate Vanadium-Evoked Glucose Metabolism In Vitro and In Vivo: Establishing Criteria for Optimal Chelators
      Itzhak Goldwaser, Sun Qian, Eytan Gershonov, Mati Fridkin and Yoram Shechter
      Molecular Pharmacology October 2000, 58 (4) 738-746; DOI: https://doi.org/10.1124/mol.58.4.738

  5. Fukuhara, Morio

    1. Aryl Hydrocarbon Receptor Is Required for p300-Mediated Induction of DNA Synthesis by Adenovirus E1A
      Masahiro Tohkin, Morio Fukuhara, Guillermo Elizondo, Shuhei Tomita and Frank J. Gonzalez
      Molecular Pharmacology October 2000, 58 (4) 845-851; DOI: https://doi.org/10.1124/mol.58.4.845

  6. Furue, Toshiaki

    1. An Analysis of the Variations in Potency of Grayanotoxin Analogs in Modifying Frog Sodium Channels of Differing Subtypes
      Masuhide Yakehiro, Tsunetsugu Yuki, Kaoru Yamaoka, Toshiaki Furue, Yasuo Mori, Keiji Imoto and Issei Seyama
      Molecular Pharmacology October 2000, 58 (4) 692-700; DOI: https://doi.org/10.1124/mol.58.4.692

G

  1. Gaido, Kevin W.

    1. Interaction of Methoxychlor and Related Compounds with Estrogen Receptor α and β, and Androgen Receptor: Structure-Activity Studies
      Kevin W. Gaido, Susan C. Maness, Donald P. McDonnell, Shangara S. Dehal, David Kupfer and Stephen Safe
      Molecular Pharmacology October 2000, 58 (4) 852-858; DOI: https://doi.org/10.1124/mol.58.4.852

  2. Galve-Roperh, Ismael

    1. The CB1 Cannabinoid Receptor Is Coupled to the Activation of c-Jun N-Terminal Kinase
      Daniel Rueda, Ismael Galve-Roperh, Amador Haro and Manuel Guzmán
      Molecular Pharmacology October 2000, 58 (4) 814-820; DOI: https://doi.org/10.1124/mol.58.4.814

  3. Gershonov, Eytan

    1. Organic Vanadium Chelators Potentiate Vanadium-Evoked Glucose Metabolism In Vitro and In Vivo: Establishing Criteria for Optimal Chelators
      Itzhak Goldwaser, Sun Qian, Eytan Gershonov, Mati Fridkin and Yoram Shechter
      Molecular Pharmacology October 2000, 58 (4) 738-746; DOI: https://doi.org/10.1124/mol.58.4.738

  4. Giniatullin, Rashid A.

    1. Rapid Relief of Block by Mecamylamine of Neuronal Nicotinic Acetylcholine Receptors of Rat Chromaffin Cells In Vitro: An Electrophysiological and Modeling Study
      Rashid A. Giniatullin, Elena M. Sokolova, Silvia Di Angelantonio, Andrei Skorinkin, Maria V. Talantova and Andrea Nistri
      Molecular Pharmacology October 2000, 58 (4) 778-787; DOI: https://doi.org/10.1124/mol.58.4.778

  5. Goldwaser, Itzhak

    1. Organic Vanadium Chelators Potentiate Vanadium-Evoked Glucose Metabolism In Vitro and In Vivo: Establishing Criteria for Optimal Chelators
      Itzhak Goldwaser, Sun Qian, Eytan Gershonov, Mati Fridkin and Yoram Shechter
      Molecular Pharmacology October 2000, 58 (4) 738-746; DOI: https://doi.org/10.1124/mol.58.4.738

  6. Gonzalez, Frank J.

    1. Aryl Hydrocarbon Receptor Is Required for p300-Mediated Induction of DNA Synthesis by Adenovirus E1A
      Masahiro Tohkin, Morio Fukuhara, Guillermo Elizondo, Shuhei Tomita and Frank J. Gonzalez
      Molecular Pharmacology October 2000, 58 (4) 845-851; DOI: https://doi.org/10.1124/mol.58.4.845

  7. Gustafson, Eric L.

    1. Identification of a Human Gastrointestinal Tract and Immune System Receptor for the Peptide Neuromedin U
      Joseph A. Hedrick, Kelley Morse, LiXin Shan, Xudong Qiao, Ling Pang, Suke Wang, Thomas Laz, Eric L. Gustafson, Marvin Bayne and Frederick J. Monsma
      Molecular Pharmacology October 2000, 58 (4) 870-875; DOI: https://doi.org/10.1124/mol.58.4.870

  8. Guzmán, Manuel

    1. The CB1 Cannabinoid Receptor Is Coupled to the Activation of c-Jun N-Terminal Kinase
      Daniel Rueda, Ismael Galve-Roperh, Amador Haro and Manuel Guzmán
      Molecular Pharmacology October 2000, 58 (4) 814-820; DOI: https://doi.org/10.1124/mol.58.4.814

H

  1. Haro, Amador

    1. The CB1 Cannabinoid Receptor Is Coupled to the Activation of c-Jun N-Terminal Kinase
      Daniel Rueda, Ismael Galve-Roperh, Amador Haro and Manuel Guzmán
      Molecular Pharmacology October 2000, 58 (4) 814-820; DOI: https://doi.org/10.1124/mol.58.4.814

  2. Haynes, Robin L.

    1. Structure-Activity Relationships for Growth Inhibition and Induction of Apoptosis by 4-Hydroxy-2-nonenal in Raw 264.7 Cells
      Robin L. Haynes, Luke Szweda, Kerry Pickin, Mark E. Welker and Alan J. Townsend
      Molecular Pharmacology October 2000, 58 (4) 788-794; DOI: https://doi.org/10.1124/mol.58.4.788

  3. Hecquet, Claudie

    1. Human Bradykinin B2 Receptor Is Activated by Kallikrein and Other Serine Proteases
      Claudie Hecquet, Fulong Tan, Branislav M. Marcic and Ervin G. Erdös
      Molecular Pharmacology October 2000, 58 (4) 828-836; DOI: https://doi.org/10.1124/mol.58.4.828

  4. Hedrick, Joseph A.

    1. Identification of a Human Gastrointestinal Tract and Immune System Receptor for the Peptide Neuromedin U
      Joseph A. Hedrick, Kelley Morse, LiXin Shan, Xudong Qiao, Ling Pang, Suke Wang, Thomas Laz, Eric L. Gustafson, Marvin Bayne and Frederick J. Monsma
      Molecular Pharmacology October 2000, 58 (4) 870-875; DOI: https://doi.org/10.1124/mol.58.4.870

  5. Hellal-Lévy, Chantal

    1. A Single Amino Acid Mutation of Ala-773 in the Mineralocorticoid Receptor Confers Agonist Properties to 11β-Substituted Spirolactones
      Gilles Auzou, Jérôme Fagart, Anny Souque, Chantal Hellal-Lévy, Jean-Marie Wurtz, Dino Moras and Marie-Edith Rafestin-Oblin
      Molecular Pharmacology October 2000, 58 (4) 684-691; DOI: https://doi.org/10.1124/mol.58.4.684

  6. Hoffmann, Ewa

    1. Duplications and Defects in the CYP2A6 Gene: Identification, Genotyping, and In Vivo Effects on Smoking
      Yushu Rao, Ewa Hoffmann, Mohammad Zia, Laurent Bodin, Marilyn Zeman, Edward M. Sellers and Rachel F. Tyndale
      Molecular Pharmacology October 2000, 58 (4) 747-755; DOI: https://doi.org/10.1124/mol.58.4.747

  7. Houshyar, Hani

    1. The Steroid 17α-Acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3,5-dien-20-one (SC17599) Is a Selective μ-Opioid Agonist: Implications for the μ-Opioid Pharmacophore
      Iain J. McFadyen, Hani Houshyar, Lee-Yuan Liu-Chen, James H. Woods and John R. Traynor
      Molecular Pharmacology October 2000, 58 (4) 669-676; DOI: https://doi.org/10.1124/mol.58.4.669

  8. Houslay, Miles D.

    1. Cell-Type Specific Integration of Cross-Talk between Extracellular Signal-Regulated Kinase and cAMP Signaling
      Miles D. Houslay and Walter Kolch
      Molecular Pharmacology October 2000, 58 (4) 659-668; DOI: https://doi.org/10.1124/mol.58.4.659

I

  1. Imoto, Keiji

    1. An Analysis of the Variations in Potency of Grayanotoxin Analogs in Modifying Frog Sodium Channels of Differing Subtypes
      Masuhide Yakehiro, Tsunetsugu Yuki, Kaoru Yamaoka, Toshiaki Furue, Yasuo Mori, Keiji Imoto and Issei Seyama
      Molecular Pharmacology October 2000, 58 (4) 692-700; DOI: https://doi.org/10.1124/mol.58.4.692

  2. Inoue, Hiroyasu

    1. 15-Deoxy-Δ12,14-prostaglandin J2Induces G1 Arrest and Differentiation Marker Expression in Vascular Smooth Muscle Cells
      Yoshikazu Miwa, Toshiyuki Sasaguri, Hiroyasu Inoue, Yoji Taba, Akio Ishida and Takeo Abumiya
      Molecular Pharmacology October 2000, 58 (4) 837-844; DOI: https://doi.org/10.1124/mol.58.4.837

  3. Ishida, Akio

    1. 15-Deoxy-Δ12,14-prostaglandin J2Induces G1 Arrest and Differentiation Marker Expression in Vascular Smooth Muscle Cells
      Yoshikazu Miwa, Toshiyuki Sasaguri, Hiroyasu Inoue, Yoji Taba, Akio Ishida and Takeo Abumiya
      Molecular Pharmacology October 2000, 58 (4) 837-844; DOI: https://doi.org/10.1124/mol.58.4.837

J

  1. Jacquemin-Sablon, Alain

    1. Cellular Resistance to the Antitumor DNA Topoisomerase II Inhibitor S16020-2: Importance of the N-[2(Dimethylamino)ethyl]carbamoyl Side Chain
      Sandrine Le Mée, Françoise Chaminade, Charlotte Delaporte, Judith Markovits, Jean-Marie Saucier and Alain Jacquemin-Sablon
      Molecular Pharmacology October 2000, 58 (4) 709-718; DOI: https://doi.org/10.1124/mol.58.4.709

K

  1. Kabbani, Nadine

    1. The Dopamine D3 Receptor Interacts with Itself and the Truncated D3 Splice Variant D3nf: D3-D3nf Interaction Causes Mislocalization of D3 Receptors
      Kelly D. Karpa, Ridwan Lin, Nadine Kabbani and Robert Levenson
      Molecular Pharmacology October 2000, 58 (4) 677-683; DOI: https://doi.org/10.1124/mol.58.4.677

  2. Karpa, Kelly D.

    1. The Dopamine D3 Receptor Interacts with Itself and the Truncated D3 Splice Variant D3nf: D3-D3nf Interaction Causes Mislocalization of D3 Receptors
      Kelly D. Karpa, Ridwan Lin, Nadine Kabbani and Robert Levenson
      Molecular Pharmacology October 2000, 58 (4) 677-683; DOI: https://doi.org/10.1124/mol.58.4.677

  3. Kehrl, John H.

    1. RGS3 Is a GTPase-Activating Protein for Giα and Gqα and a Potent Inhibitor of Signaling by GTPase-Deficient Forms of Gqα and G11α
      Astrid Scheschonka, Carmen W. Dessauer, Srikumar Sinnarajah, Peter Chidiac, Chong-Shan Shi and John H. Kehrl
      Molecular Pharmacology October 2000, 58 (4) 719-728; DOI: https://doi.org/10.1124/mol.58.4.719

  4. Kessler, Markus

    1. Effects of the Potent Ampakine CX614 on Hippocampal and Recombinant AMPA Receptors: Interactions with Cyclothiazide and GYKI 52466
      Amy C. Arai, Markus Kessler, Gary Rogers and Gary Lynch
      Molecular Pharmacology October 2000, 58 (4) 802-813; DOI: https://doi.org/10.1124/mol.58.4.802

  5. Kolch, Walter

    1. Cell-Type Specific Integration of Cross-Talk between Extracellular Signal-Regulated Kinase and cAMP Signaling
      Miles D. Houslay and Walter Kolch
      Molecular Pharmacology October 2000, 58 (4) 659-668; DOI: https://doi.org/10.1124/mol.58.4.659

  6. Kull, Björn

    1. Adenosine A2A Receptors are Colocalized with and Activate Golf in Rat Striatum
      Björn Kull, Per Svenningsson and Bertil B. Fredholm
      Molecular Pharmacology October 2000, 58 (4) 771-777; DOI: https://doi.org/10.1124/mol.58.4.771

  7. Kupfer, David

    1. Interaction of Methoxychlor and Related Compounds with Estrogen Receptor α and β, and Androgen Receptor: Structure-Activity Studies
      Kevin W. Gaido, Susan C. Maness, Donald P. McDonnell, Shangara S. Dehal, David Kupfer and Stephen Safe
      Molecular Pharmacology October 2000, 58 (4) 852-858; DOI: https://doi.org/10.1124/mol.58.4.852

L

  1. Lan, Lu-Bin

    1. Mdr1 Limits CYP3A Metabolism in Vivo
      Lu-Bin Lan, James T. Dalton and Erin G. Schuetz
      Molecular Pharmacology October 2000, 58 (4) 863-869; DOI: https://doi.org/10.1124/mol.58.4.863

  2. Laz, Thomas

    1. Identification of a Human Gastrointestinal Tract and Immune System Receptor for the Peptide Neuromedin U
      Joseph A. Hedrick, Kelley Morse, LiXin Shan, Xudong Qiao, Ling Pang, Suke Wang, Thomas Laz, Eric L. Gustafson, Marvin Bayne and Frederick J. Monsma
      Molecular Pharmacology October 2000, 58 (4) 870-875; DOI: https://doi.org/10.1124/mol.58.4.870

  3. Le Mée, Sandrine

    1. Cellular Resistance to the Antitumor DNA Topoisomerase II Inhibitor S16020-2: Importance of the N-[2(Dimethylamino)ethyl]carbamoyl Side Chain
      Sandrine Le Mée, Françoise Chaminade, Charlotte Delaporte, Judith Markovits, Jean-Marie Saucier and Alain Jacquemin-Sablon
      Molecular Pharmacology October 2000, 58 (4) 709-718; DOI: https://doi.org/10.1124/mol.58.4.709

  4. Levenson, Robert

    1. The Dopamine D3 Receptor Interacts with Itself and the Truncated D3 Splice Variant D3nf: D3-D3nf Interaction Causes Mislocalization of D3 Receptors
      Kelly D. Karpa, Ridwan Lin, Nadine Kabbani and Robert Levenson
      Molecular Pharmacology October 2000, 58 (4) 677-683; DOI: https://doi.org/10.1124/mol.58.4.677

  5. Li, Jian-Guo

    1. Mechanisms of Agonist-Induced Down-Regulation of the Human κ-Opioid Receptor: Internalization Is Required for Down-Regulation
      Jian-Guo Li, Jeffrey L. Benovic and Lee-Yuan Liu-Chen
      Molecular Pharmacology October 2000, 58 (4) 795-801; DOI: https://doi.org/10.1124/mol.58.4.795

  6. Lin, Ridwan

    1. The Dopamine D3 Receptor Interacts with Itself and the Truncated D3 Splice Variant D3nf: D3-D3nf Interaction Causes Mislocalization of D3 Receptors
      Kelly D. Karpa, Ridwan Lin, Nadine Kabbani and Robert Levenson
      Molecular Pharmacology October 2000, 58 (4) 677-683; DOI: https://doi.org/10.1124/mol.58.4.677

  7. Liu-Chen, Lee-Yuan

    1. The Steroid 17α-Acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3,5-dien-20-one (SC17599) Is a Selective μ-Opioid Agonist: Implications for the μ-Opioid Pharmacophore
      Iain J. McFadyen, Hani Houshyar, Lee-Yuan Liu-Chen, James H. Woods and John R. Traynor
      Molecular Pharmacology October 2000, 58 (4) 669-676; DOI: https://doi.org/10.1124/mol.58.4.669
    2. Mechanisms of Agonist-Induced Down-Regulation of the Human κ-Opioid Receptor: Internalization Is Required for Down-Regulation
      Jian-Guo Li, Jeffrey L. Benovic and Lee-Yuan Liu-Chen
      Molecular Pharmacology October 2000, 58 (4) 795-801; DOI: https://doi.org/10.1124/mol.58.4.795

  8. Lymperopoulos, Anastasios

    1. Transcriptional Down-Regulation of the Human α2C-Adrenergic Receptor by cAMP
      Stéphane Schaak, Cécile Cayla, Anastasios Lymperopoulos, Christodoulos Flordellis, Daniel Cussac, Colette Denis and Hervé Paris
      Molecular Pharmacology October 2000, 58 (4) 821-827; DOI: https://doi.org/10.1124/mol.58.4.821

  9. Lynch, Gary

    1. Effects of the Potent Ampakine CX614 on Hippocampal and Recombinant AMPA Receptors: Interactions with Cyclothiazide and GYKI 52466
      Amy C. Arai, Markus Kessler, Gary Rogers and Gary Lynch
      Molecular Pharmacology October 2000, 58 (4) 802-813; DOI: https://doi.org/10.1124/mol.58.4.802

M

  1. Maness, Susan C.

    1. Interaction of Methoxychlor and Related Compounds with Estrogen Receptor α and β, and Androgen Receptor: Structure-Activity Studies
      Kevin W. Gaido, Susan C. Maness, Donald P. McDonnell, Shangara S. Dehal, David Kupfer and Stephen Safe
      Molecular Pharmacology October 2000, 58 (4) 852-858; DOI: https://doi.org/10.1124/mol.58.4.852

  2. Marcic, Branislav M.

    1. Human Bradykinin B2 Receptor Is Activated by Kallikrein and Other Serine Proteases
      Claudie Hecquet, Fulong Tan, Branislav M. Marcic and Ervin G. Erdös
      Molecular Pharmacology October 2000, 58 (4) 828-836; DOI: https://doi.org/10.1124/mol.58.4.828

  3. Markovits, Judith

    1. Cellular Resistance to the Antitumor DNA Topoisomerase II Inhibitor S16020-2: Importance of the N-[2(Dimethylamino)ethyl]carbamoyl Side Chain
      Sandrine Le Mée, Françoise Chaminade, Charlotte Delaporte, Judith Markovits, Jean-Marie Saucier and Alain Jacquemin-Sablon
      Molecular Pharmacology October 2000, 58 (4) 709-718; DOI: https://doi.org/10.1124/mol.58.4.709

  4. Marshall, John F.

    1. Photo-Induced Inactivation of Protein Kinase Cα by Dequalinium Inhibits Motility of Murine Melanoma Cells
      Regina M. Sullivan, Michael Stone, John F. Marshall, Florian Uberall and Susan A. Rotenberg
      Molecular Pharmacology October 2000, 58 (4) 729-737; DOI: https://doi.org/10.1124/mol.58.4.729

  5. Martin, Ian L.

    1. Characterization of the Interaction of Zopiclone with γ-Aminobutyric Acid Type A Receptors
      Martin Davies, J. Glen Newell, Jason M. C. Derry, Ian L. Martin and Susan M. J. Dunn
      Molecular Pharmacology October 2000, 58 (4) 756-762; DOI: https://doi.org/10.1124/mol.58.4.756

  6. McDonnell, Donald P.

    1. Interaction of Methoxychlor and Related Compounds with Estrogen Receptor α and β, and Androgen Receptor: Structure-Activity Studies
      Kevin W. Gaido, Susan C. Maness, Donald P. McDonnell, Shangara S. Dehal, David Kupfer and Stephen Safe
      Molecular Pharmacology October 2000, 58 (4) 852-858; DOI: https://doi.org/10.1124/mol.58.4.852

  7. McFadyen, Iain J.

    1. The Steroid 17α-Acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3,5-dien-20-one (SC17599) Is a Selective μ-Opioid Agonist: Implications for the μ-Opioid Pharmacophore
      Iain J. McFadyen, Hani Houshyar, Lee-Yuan Liu-Chen, James H. Woods and John R. Traynor
      Molecular Pharmacology October 2000, 58 (4) 669-676; DOI: https://doi.org/10.1124/mol.58.4.669

  8. Miwa, Yoshikazu

    1. 15-Deoxy-Δ12,14-prostaglandin J2Induces G1 Arrest and Differentiation Marker Expression in Vascular Smooth Muscle Cells
      Yoshikazu Miwa, Toshiyuki Sasaguri, Hiroyasu Inoue, Yoji Taba, Akio Ishida and Takeo Abumiya
      Molecular Pharmacology October 2000, 58 (4) 837-844; DOI: https://doi.org/10.1124/mol.58.4.837

  9. Monsma, Frederick J.

    1. Identification of a Human Gastrointestinal Tract and Immune System Receptor for the Peptide Neuromedin U
      Joseph A. Hedrick, Kelley Morse, LiXin Shan, Xudong Qiao, Ling Pang, Suke Wang, Thomas Laz, Eric L. Gustafson, Marvin Bayne and Frederick J. Monsma
      Molecular Pharmacology October 2000, 58 (4) 870-875; DOI: https://doi.org/10.1124/mol.58.4.870

  10. Moras, Dino

    1. A Single Amino Acid Mutation of Ala-773 in the Mineralocorticoid Receptor Confers Agonist Properties to 11β-Substituted Spirolactones
      Gilles Auzou, Jérôme Fagart, Anny Souque, Chantal Hellal-Lévy, Jean-Marie Wurtz, Dino Moras and Marie-Edith Rafestin-Oblin
      Molecular Pharmacology October 2000, 58 (4) 684-691; DOI: https://doi.org/10.1124/mol.58.4.684

  11. Mori, Yasuo

    1. An Analysis of the Variations in Potency of Grayanotoxin Analogs in Modifying Frog Sodium Channels of Differing Subtypes
      Masuhide Yakehiro, Tsunetsugu Yuki, Kaoru Yamaoka, Toshiaki Furue, Yasuo Mori, Keiji Imoto and Issei Seyama
      Molecular Pharmacology October 2000, 58 (4) 692-700; DOI: https://doi.org/10.1124/mol.58.4.692

  12. Morse, Kelley

    1. Identification of a Human Gastrointestinal Tract and Immune System Receptor for the Peptide Neuromedin U
      Joseph A. Hedrick, Kelley Morse, LiXin Shan, Xudong Qiao, Ling Pang, Suke Wang, Thomas Laz, Eric L. Gustafson, Marvin Bayne and Frederick J. Monsma
      Molecular Pharmacology October 2000, 58 (4) 870-875; DOI: https://doi.org/10.1124/mol.58.4.870

  13. Murphy, T. J.

    1. Cyclosporin A Selectively Inhibits Mitogen-Induced Cyclooxygenase-2 Gene Transcription in Vascular Smooth Muscle Cells
      Aaron M. Robida, Kaiming Xu, Michelle L. Ellington and T. J. Murphy
      Molecular Pharmacology October 2000, 58 (4) 701-708; DOI: https://doi.org/10.1124/mol.58.4.701

N

  1. Newell, J. Glen

    1. Characterization of the Interaction of Zopiclone with γ-Aminobutyric Acid Type A Receptors
      Martin Davies, J. Glen Newell, Jason M. C. Derry, Ian L. Martin and Susan M. J. Dunn
      Molecular Pharmacology October 2000, 58 (4) 756-762; DOI: https://doi.org/10.1124/mol.58.4.756

  2. Nistri, Andrea

    1. Rapid Relief of Block by Mecamylamine of Neuronal Nicotinic Acetylcholine Receptors of Rat Chromaffin Cells In Vitro: An Electrophysiological and Modeling Study
      Rashid A. Giniatullin, Elena M. Sokolova, Silvia Di Angelantonio, Andrei Skorinkin, Maria V. Talantova and Andrea Nistri
      Molecular Pharmacology October 2000, 58 (4) 778-787; DOI: https://doi.org/10.1124/mol.58.4.778

P

  1. Pang, Ling

    1. Identification of a Human Gastrointestinal Tract and Immune System Receptor for the Peptide Neuromedin U
      Joseph A. Hedrick, Kelley Morse, LiXin Shan, Xudong Qiao, Ling Pang, Suke Wang, Thomas Laz, Eric L. Gustafson, Marvin Bayne and Frederick J. Monsma
      Molecular Pharmacology October 2000, 58 (4) 870-875; DOI: https://doi.org/10.1124/mol.58.4.870

  2. Paris, Hervé

    1. Transcriptional Down-Regulation of the Human α2C-Adrenergic Receptor by cAMP
      Stéphane Schaak, Cécile Cayla, Anastasios Lymperopoulos, Christodoulos Flordellis, Daniel Cussac, Colette Denis and Hervé Paris
      Molecular Pharmacology October 2000, 58 (4) 821-827; DOI: https://doi.org/10.1124/mol.58.4.821

  3. Pickin, Kerry

    1. Structure-Activity Relationships for Growth Inhibition and Induction of Apoptosis by 4-Hydroxy-2-nonenal in Raw 264.7 Cells
      Robin L. Haynes, Luke Szweda, Kerry Pickin, Mark E. Welker and Alan J. Townsend
      Molecular Pharmacology October 2000, 58 (4) 788-794; DOI: https://doi.org/10.1124/mol.58.4.788

  4. Price, Raymond D.

    1. RNA Editing of the Human Serotonin 5-HT2C Receptor Delays Agonist-Stimulated Calcium Release
      Raymond D. Price and Elaine Sanders-Bush
      Molecular Pharmacology October 2000, 58 (4) 859-862; DOI: https://doi.org/10.1124/mol.58.4.859

Q

  1. Qian, Sun

    1. Organic Vanadium Chelators Potentiate Vanadium-Evoked Glucose Metabolism In Vitro and In Vivo: Establishing Criteria for Optimal Chelators
      Itzhak Goldwaser, Sun Qian, Eytan Gershonov, Mati Fridkin and Yoram Shechter
      Molecular Pharmacology October 2000, 58 (4) 738-746; DOI: https://doi.org/10.1124/mol.58.4.738

  2. Qiao, Xudong

    1. Identification of a Human Gastrointestinal Tract and Immune System Receptor for the Peptide Neuromedin U
      Joseph A. Hedrick, Kelley Morse, LiXin Shan, Xudong Qiao, Ling Pang, Suke Wang, Thomas Laz, Eric L. Gustafson, Marvin Bayne and Frederick J. Monsma
      Molecular Pharmacology October 2000, 58 (4) 870-875; DOI: https://doi.org/10.1124/mol.58.4.870

R

  1. Rafestin-Oblin, Marie-Edith

    1. A Single Amino Acid Mutation of Ala-773 in the Mineralocorticoid Receptor Confers Agonist Properties to 11β-Substituted Spirolactones
      Gilles Auzou, Jérôme Fagart, Anny Souque, Chantal Hellal-Lévy, Jean-Marie Wurtz, Dino Moras and Marie-Edith Rafestin-Oblin
      Molecular Pharmacology October 2000, 58 (4) 684-691; DOI: https://doi.org/10.1124/mol.58.4.684

  2. Rao, Yushu

    1. Duplications and Defects in the CYP2A6 Gene: Identification, Genotyping, and In Vivo Effects on Smoking
      Yushu Rao, Ewa Hoffmann, Mohammad Zia, Laurent Bodin, Marilyn Zeman, Edward M. Sellers and Rachel F. Tyndale
      Molecular Pharmacology October 2000, 58 (4) 747-755; DOI: https://doi.org/10.1124/mol.58.4.747

  3. Robida, Aaron M.

    1. Cyclosporin A Selectively Inhibits Mitogen-Induced Cyclooxygenase-2 Gene Transcription in Vascular Smooth Muscle Cells
      Aaron M. Robida, Kaiming Xu, Michelle L. Ellington and T. J. Murphy
      Molecular Pharmacology October 2000, 58 (4) 701-708; DOI: https://doi.org/10.1124/mol.58.4.701

  4. Rogers, Gary

    1. Effects of the Potent Ampakine CX614 on Hippocampal and Recombinant AMPA Receptors: Interactions with Cyclothiazide and GYKI 52466
      Amy C. Arai, Markus Kessler, Gary Rogers and Gary Lynch
      Molecular Pharmacology October 2000, 58 (4) 802-813; DOI: https://doi.org/10.1124/mol.58.4.802

  5. Rotenberg, Susan A.

    1. Photo-Induced Inactivation of Protein Kinase Cα by Dequalinium Inhibits Motility of Murine Melanoma Cells
      Regina M. Sullivan, Michael Stone, John F. Marshall, Florian Uberall and Susan A. Rotenberg
      Molecular Pharmacology October 2000, 58 (4) 729-737; DOI: https://doi.org/10.1124/mol.58.4.729

  6. Rueda, Daniel

    1. The CB1 Cannabinoid Receptor Is Coupled to the Activation of c-Jun N-Terminal Kinase
      Daniel Rueda, Ismael Galve-Roperh, Amador Haro and Manuel Guzmán
      Molecular Pharmacology October 2000, 58 (4) 814-820; DOI: https://doi.org/10.1124/mol.58.4.814

S

  1. Safe, Stephen

    1. Interaction of Methoxychlor and Related Compounds with Estrogen Receptor α and β, and Androgen Receptor: Structure-Activity Studies
      Kevin W. Gaido, Susan C. Maness, Donald P. McDonnell, Shangara S. Dehal, David Kupfer and Stephen Safe
      Molecular Pharmacology October 2000, 58 (4) 852-858; DOI: https://doi.org/10.1124/mol.58.4.852

  2. Sanders-Bush, Elaine

    1. RNA Editing of the Human Serotonin 5-HT2C Receptor Delays Agonist-Stimulated Calcium Release
      Raymond D. Price and Elaine Sanders-Bush
      Molecular Pharmacology October 2000, 58 (4) 859-862; DOI: https://doi.org/10.1124/mol.58.4.859

  3. Sasaguri, Toshiyuki

    1. 15-Deoxy-Δ12,14-prostaglandin J2Induces G1 Arrest and Differentiation Marker Expression in Vascular Smooth Muscle Cells
      Yoshikazu Miwa, Toshiyuki Sasaguri, Hiroyasu Inoue, Yoji Taba, Akio Ishida and Takeo Abumiya
      Molecular Pharmacology October 2000, 58 (4) 837-844; DOI: https://doi.org/10.1124/mol.58.4.837

  4. Saucier, Jean-Marie

    1. Cellular Resistance to the Antitumor DNA Topoisomerase II Inhibitor S16020-2: Importance of the N-[2(Dimethylamino)ethyl]carbamoyl Side Chain
      Sandrine Le Mée, Françoise Chaminade, Charlotte Delaporte, Judith Markovits, Jean-Marie Saucier and Alain Jacquemin-Sablon
      Molecular Pharmacology October 2000, 58 (4) 709-718; DOI: https://doi.org/10.1124/mol.58.4.709

  5. Schaak, Stéphane

    1. Transcriptional Down-Regulation of the Human α2C-Adrenergic Receptor by cAMP
      Stéphane Schaak, Cécile Cayla, Anastasios Lymperopoulos, Christodoulos Flordellis, Daniel Cussac, Colette Denis and Hervé Paris
      Molecular Pharmacology October 2000, 58 (4) 821-827; DOI: https://doi.org/10.1124/mol.58.4.821

  6. Scheschonka, Astrid

    1. RGS3 Is a GTPase-Activating Protein for Giα and Gqα and a Potent Inhibitor of Signaling by GTPase-Deficient Forms of Gqα and G11α
      Astrid Scheschonka, Carmen W. Dessauer, Srikumar Sinnarajah, Peter Chidiac, Chong-Shan Shi and John H. Kehrl
      Molecular Pharmacology October 2000, 58 (4) 719-728; DOI: https://doi.org/10.1124/mol.58.4.719

  7. Schuetz, Erin G.

    1. Mdr1 Limits CYP3A Metabolism in Vivo
      Lu-Bin Lan, James T. Dalton and Erin G. Schuetz
      Molecular Pharmacology October 2000, 58 (4) 863-869; DOI: https://doi.org/10.1124/mol.58.4.863

  8. Sellers, Edward M.

    1. Duplications and Defects in the CYP2A6 Gene: Identification, Genotyping, and In Vivo Effects on Smoking
      Yushu Rao, Ewa Hoffmann, Mohammad Zia, Laurent Bodin, Marilyn Zeman, Edward M. Sellers and Rachel F. Tyndale
      Molecular Pharmacology October 2000, 58 (4) 747-755; DOI: https://doi.org/10.1124/mol.58.4.747

  9. Seyama, Issei

    1. An Analysis of the Variations in Potency of Grayanotoxin Analogs in Modifying Frog Sodium Channels of Differing Subtypes
      Masuhide Yakehiro, Tsunetsugu Yuki, Kaoru Yamaoka, Toshiaki Furue, Yasuo Mori, Keiji Imoto and Issei Seyama
      Molecular Pharmacology October 2000, 58 (4) 692-700; DOI: https://doi.org/10.1124/mol.58.4.692

  10. Shan, LiXin

    1. Identification of a Human Gastrointestinal Tract and Immune System Receptor for the Peptide Neuromedin U
      Joseph A. Hedrick, Kelley Morse, LiXin Shan, Xudong Qiao, Ling Pang, Suke Wang, Thomas Laz, Eric L. Gustafson, Marvin Bayne and Frederick J. Monsma
      Molecular Pharmacology October 2000, 58 (4) 870-875; DOI: https://doi.org/10.1124/mol.58.4.870

  11. Shechter, Yoram

    1. Organic Vanadium Chelators Potentiate Vanadium-Evoked Glucose Metabolism In Vitro and In Vivo: Establishing Criteria for Optimal Chelators
      Itzhak Goldwaser, Sun Qian, Eytan Gershonov, Mati Fridkin and Yoram Shechter
      Molecular Pharmacology October 2000, 58 (4) 738-746; DOI: https://doi.org/10.1124/mol.58.4.738

  12. Shi, Chong-Shan

    1. RGS3 Is a GTPase-Activating Protein for Giα and Gqα and a Potent Inhibitor of Signaling by GTPase-Deficient Forms of Gqα and G11α
      Astrid Scheschonka, Carmen W. Dessauer, Srikumar Sinnarajah, Peter Chidiac, Chong-Shan Shi and John H. Kehrl
      Molecular Pharmacology October 2000, 58 (4) 719-728; DOI: https://doi.org/10.1124/mol.58.4.719

  13. Sinnarajah, Srikumar

    1. RGS3 Is a GTPase-Activating Protein for Giα and Gqα and a Potent Inhibitor of Signaling by GTPase-Deficient Forms of Gqα and G11α
      Astrid Scheschonka, Carmen W. Dessauer, Srikumar Sinnarajah, Peter Chidiac, Chong-Shan Shi and John H. Kehrl
      Molecular Pharmacology October 2000, 58 (4) 719-728; DOI: https://doi.org/10.1124/mol.58.4.719

  14. Skorinkin, Andrei

    1. Rapid Relief of Block by Mecamylamine of Neuronal Nicotinic Acetylcholine Receptors of Rat Chromaffin Cells In Vitro: An Electrophysiological and Modeling Study
      Rashid A. Giniatullin, Elena M. Sokolova, Silvia Di Angelantonio, Andrei Skorinkin, Maria V. Talantova and Andrea Nistri
      Molecular Pharmacology October 2000, 58 (4) 778-787; DOI: https://doi.org/10.1124/mol.58.4.778

  15. Sokolova, Elena M.

    1. Rapid Relief of Block by Mecamylamine of Neuronal Nicotinic Acetylcholine Receptors of Rat Chromaffin Cells In Vitro: An Electrophysiological and Modeling Study
      Rashid A. Giniatullin, Elena M. Sokolova, Silvia Di Angelantonio, Andrei Skorinkin, Maria V. Talantova and Andrea Nistri
      Molecular Pharmacology October 2000, 58 (4) 778-787; DOI: https://doi.org/10.1124/mol.58.4.778

  16. Souque, Anny

    1. A Single Amino Acid Mutation of Ala-773 in the Mineralocorticoid Receptor Confers Agonist Properties to 11β-Substituted Spirolactones
      Gilles Auzou, Jérôme Fagart, Anny Souque, Chantal Hellal-Lévy, Jean-Marie Wurtz, Dino Moras and Marie-Edith Rafestin-Oblin
      Molecular Pharmacology October 2000, 58 (4) 684-691; DOI: https://doi.org/10.1124/mol.58.4.684

  17. Stone, Michael

    1. Photo-Induced Inactivation of Protein Kinase Cα by Dequalinium Inhibits Motility of Murine Melanoma Cells
      Regina M. Sullivan, Michael Stone, John F. Marshall, Florian Uberall and Susan A. Rotenberg
      Molecular Pharmacology October 2000, 58 (4) 729-737; DOI: https://doi.org/10.1124/mol.58.4.729

  18. Sullivan, Regina M.

    1. Photo-Induced Inactivation of Protein Kinase Cα by Dequalinium Inhibits Motility of Murine Melanoma Cells
      Regina M. Sullivan, Michael Stone, John F. Marshall, Florian Uberall and Susan A. Rotenberg
      Molecular Pharmacology October 2000, 58 (4) 729-737; DOI: https://doi.org/10.1124/mol.58.4.729

  19. Supplisson, Stephane

    1. Glycine Receptor β Subunits Play a Critical Role in Potentiation of Glycine Responses by ICS-205,930
      Stephane Supplisson and Dominique Chesnoy-Marchais
      Molecular Pharmacology October 2000, 58 (4) 763-770; DOI: https://doi.org/10.1124/mol.58.4.763

  20. Svenningsson, Per

    1. Adenosine A2A Receptors are Colocalized with and Activate Golf in Rat Striatum
      Björn Kull, Per Svenningsson and Bertil B. Fredholm
      Molecular Pharmacology October 2000, 58 (4) 771-777; DOI: https://doi.org/10.1124/mol.58.4.771

  21. Szweda, Luke

    1. Structure-Activity Relationships for Growth Inhibition and Induction of Apoptosis by 4-Hydroxy-2-nonenal in Raw 264.7 Cells
      Robin L. Haynes, Luke Szweda, Kerry Pickin, Mark E. Welker and Alan J. Townsend
      Molecular Pharmacology October 2000, 58 (4) 788-794; DOI: https://doi.org/10.1124/mol.58.4.788

T

  1. Taba, Yoji

    1. 15-Deoxy-Δ12,14-prostaglandin J2Induces G1 Arrest and Differentiation Marker Expression in Vascular Smooth Muscle Cells
      Yoshikazu Miwa, Toshiyuki Sasaguri, Hiroyasu Inoue, Yoji Taba, Akio Ishida and Takeo Abumiya
      Molecular Pharmacology October 2000, 58 (4) 837-844; DOI: https://doi.org/10.1124/mol.58.4.837

  2. Talantova, Maria V.

    1. Rapid Relief of Block by Mecamylamine of Neuronal Nicotinic Acetylcholine Receptors of Rat Chromaffin Cells In Vitro: An Electrophysiological and Modeling Study
      Rashid A. Giniatullin, Elena M. Sokolova, Silvia Di Angelantonio, Andrei Skorinkin, Maria V. Talantova and Andrea Nistri
      Molecular Pharmacology October 2000, 58 (4) 778-787; DOI: https://doi.org/10.1124/mol.58.4.778

  3. Tan, Fulong

    1. Human Bradykinin B2 Receptor Is Activated by Kallikrein and Other Serine Proteases
      Claudie Hecquet, Fulong Tan, Branislav M. Marcic and Ervin G. Erdös
      Molecular Pharmacology October 2000, 58 (4) 828-836; DOI: https://doi.org/10.1124/mol.58.4.828

  4. Tohkin, Masahiro

    1. Aryl Hydrocarbon Receptor Is Required for p300-Mediated Induction of DNA Synthesis by Adenovirus E1A
      Masahiro Tohkin, Morio Fukuhara, Guillermo Elizondo, Shuhei Tomita and Frank J. Gonzalez
      Molecular Pharmacology October 2000, 58 (4) 845-851; DOI: https://doi.org/10.1124/mol.58.4.845

  5. Tomita, Shuhei

    1. Aryl Hydrocarbon Receptor Is Required for p300-Mediated Induction of DNA Synthesis by Adenovirus E1A
      Masahiro Tohkin, Morio Fukuhara, Guillermo Elizondo, Shuhei Tomita and Frank J. Gonzalez
      Molecular Pharmacology October 2000, 58 (4) 845-851; DOI: https://doi.org/10.1124/mol.58.4.845

  6. Townsend, Alan J.

    1. Structure-Activity Relationships for Growth Inhibition and Induction of Apoptosis by 4-Hydroxy-2-nonenal in Raw 264.7 Cells
      Robin L. Haynes, Luke Szweda, Kerry Pickin, Mark E. Welker and Alan J. Townsend
      Molecular Pharmacology October 2000, 58 (4) 788-794; DOI: https://doi.org/10.1124/mol.58.4.788

  7. Traynor, John R.

    1. The Steroid 17α-Acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3,5-dien-20-one (SC17599) Is a Selective μ-Opioid Agonist: Implications for the μ-Opioid Pharmacophore
      Iain J. McFadyen, Hani Houshyar, Lee-Yuan Liu-Chen, James H. Woods and John R. Traynor
      Molecular Pharmacology October 2000, 58 (4) 669-676; DOI: https://doi.org/10.1124/mol.58.4.669

  8. Tyndale, Rachel F.

    1. Duplications and Defects in the CYP2A6 Gene: Identification, Genotyping, and In Vivo Effects on Smoking
      Yushu Rao, Ewa Hoffmann, Mohammad Zia, Laurent Bodin, Marilyn Zeman, Edward M. Sellers and Rachel F. Tyndale
      Molecular Pharmacology October 2000, 58 (4) 747-755; DOI: https://doi.org/10.1124/mol.58.4.747

U

  1. Uberall, Florian

    1. Photo-Induced Inactivation of Protein Kinase Cα by Dequalinium Inhibits Motility of Murine Melanoma Cells
      Regina M. Sullivan, Michael Stone, John F. Marshall, Florian Uberall and Susan A. Rotenberg
      Molecular Pharmacology October 2000, 58 (4) 729-737; DOI: https://doi.org/10.1124/mol.58.4.729

W

  1. Wang, Suke

    1. Identification of a Human Gastrointestinal Tract and Immune System Receptor for the Peptide Neuromedin U
      Joseph A. Hedrick, Kelley Morse, LiXin Shan, Xudong Qiao, Ling Pang, Suke Wang, Thomas Laz, Eric L. Gustafson, Marvin Bayne and Frederick J. Monsma
      Molecular Pharmacology October 2000, 58 (4) 870-875; DOI: https://doi.org/10.1124/mol.58.4.870

  2. Welker, Mark E.

    1. Structure-Activity Relationships for Growth Inhibition and Induction of Apoptosis by 4-Hydroxy-2-nonenal in Raw 264.7 Cells
      Robin L. Haynes, Luke Szweda, Kerry Pickin, Mark E. Welker and Alan J. Townsend
      Molecular Pharmacology October 2000, 58 (4) 788-794; DOI: https://doi.org/10.1124/mol.58.4.788

  3. Woods, James H.

    1. The Steroid 17α-Acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3,5-dien-20-one (SC17599) Is a Selective μ-Opioid Agonist: Implications for the μ-Opioid Pharmacophore
      Iain J. McFadyen, Hani Houshyar, Lee-Yuan Liu-Chen, James H. Woods and John R. Traynor
      Molecular Pharmacology October 2000, 58 (4) 669-676; DOI: https://doi.org/10.1124/mol.58.4.669

  4. Wurtz, Jean-Marie

    1. A Single Amino Acid Mutation of Ala-773 in the Mineralocorticoid Receptor Confers Agonist Properties to 11β-Substituted Spirolactones
      Gilles Auzou, Jérôme Fagart, Anny Souque, Chantal Hellal-Lévy, Jean-Marie Wurtz, Dino Moras and Marie-Edith Rafestin-Oblin
      Molecular Pharmacology October 2000, 58 (4) 684-691; DOI: https://doi.org/10.1124/mol.58.4.684

X

  1. Xu, Kaiming

    1. Cyclosporin A Selectively Inhibits Mitogen-Induced Cyclooxygenase-2 Gene Transcription in Vascular Smooth Muscle Cells
      Aaron M. Robida, Kaiming Xu, Michelle L. Ellington and T. J. Murphy
      Molecular Pharmacology October 2000, 58 (4) 701-708; DOI: https://doi.org/10.1124/mol.58.4.701

Y

  1. Yakehiro, Masuhide

    1. An Analysis of the Variations in Potency of Grayanotoxin Analogs in Modifying Frog Sodium Channels of Differing Subtypes
      Masuhide Yakehiro, Tsunetsugu Yuki, Kaoru Yamaoka, Toshiaki Furue, Yasuo Mori, Keiji Imoto and Issei Seyama
      Molecular Pharmacology October 2000, 58 (4) 692-700; DOI: https://doi.org/10.1124/mol.58.4.692

  2. Yamaoka, Kaoru

    1. An Analysis of the Variations in Potency of Grayanotoxin Analogs in Modifying Frog Sodium Channels of Differing Subtypes
      Masuhide Yakehiro, Tsunetsugu Yuki, Kaoru Yamaoka, Toshiaki Furue, Yasuo Mori, Keiji Imoto and Issei Seyama
      Molecular Pharmacology October 2000, 58 (4) 692-700; DOI: https://doi.org/10.1124/mol.58.4.692

  3. Yuki, Tsunetsugu

    1. An Analysis of the Variations in Potency of Grayanotoxin Analogs in Modifying Frog Sodium Channels of Differing Subtypes
      Masuhide Yakehiro, Tsunetsugu Yuki, Kaoru Yamaoka, Toshiaki Furue, Yasuo Mori, Keiji Imoto and Issei Seyama
      Molecular Pharmacology October 2000, 58 (4) 692-700; DOI: https://doi.org/10.1124/mol.58.4.692

Z

  1. Zeman, Marilyn

    1. Duplications and Defects in the CYP2A6 Gene: Identification, Genotyping, and In Vivo Effects on Smoking
      Yushu Rao, Ewa Hoffmann, Mohammad Zia, Laurent Bodin, Marilyn Zeman, Edward M. Sellers and Rachel F. Tyndale
      Molecular Pharmacology October 2000, 58 (4) 747-755; DOI: https://doi.org/10.1124/mol.58.4.747

  2. Zia, Mohammad

    1. Duplications and Defects in the CYP2A6 Gene: Identification, Genotyping, and In Vivo Effects on Smoking
      Yushu Rao, Ewa Hoffmann, Mohammad Zia, Laurent Bodin, Marilyn Zeman, Edward M. Sellers and Rachel F. Tyndale
      Molecular Pharmacology October 2000, 58 (4) 747-755; DOI: https://doi.org/10.1124/mol.58.4.747
Back to top

In this issue